Back

The correlation between the PRAETORIAN Score in Subcutaneous Implantable Defibrillator Patients and the Defibrillation Threshold.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death Device Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Anne-Floor Barbara Eleonore Quast

Academic Medical Centre, Amsterdam (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Prediction of ventricular tachyarrhythmias occurrence by changes in physiological parameters derived from implantable-cardioverter defibrillators
Doctor N. Chan (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
An evaluation of the effect of the subcutaneous implantable defibrillator smartpass filter on inappropriate shock reduction.
Doctor T. Brouwer (Amsterdam, NL)
Abstract
Presentation thumbnail
Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction
Doctor M. Kawasaki (Osaka, JP)
Abstract Slides
Presentation thumbnail
The effectiveness of the wearable cardioverter defibrillator in a real world environment
Doctor C. Abrahim (Springfield, US)
Abstract Slides
Presentation thumbnail
Sudden cardiac arrest in patients with cardiac implantable electronic devices
Doctor A. Sharifzadehgan (Paris, FR)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources